DSCAM and cancer: Overlapping with our ongoing study, in the end of 2021 a study has been published reporting DSCAM-AS1 overexpression in endometrial cancer tissue and suggested this lncRNA facilitates cancer progression by upregulation of miR-136-5p [25].